News | August 02, 2024
GlaxoSmithKline Pharmaceuticals reports Q1 FY25 PAT at Rs. 182 Cr
Strong topline growth driven by solid performance across key brands.
Strong topline growth driven by solid performance across key brands.
Ajanta Pharma has reported total income of Rs. 1,171.39 crores during the period ended June 30, 2024
Ursodeoxycholic acid or ursodiol is a naturally occurring bile acid that is used dissolve cholesterol gall stones
The revenue for the Q1FY25 came in at Rs 1,085.7 crore, up 16.6 per cent YoY
Fredun Pharmaceuticals has reported total income of Rs. 78.81 crores during the period ended June 30, 2024
These gummies are specially formulated for both kids and adults to nourish the eyes and promote optimal vision development
Indoco Remedies is addressing the observations comprehensively and will respond to the USFDA within the stipulated timeframe
Acquisition in line with Mankind’s stated objective to expand its presence in high entry barrier complex portfolios and high potential OTX brands
The partnership will significantly advance their sustainability initiatives by meeting around 67% of their power requirements for these plants
The inspection was concluded with two 483 observations
Subscribe To Our Newsletter & Stay Updated
